home › Nya metoder, rön och studier › Biologix Hår kongress

  • Post
  • Biologix Hair To Exhibit At The 11th Annual Anti-Aging Medicine World Congress, Grimaldi Forum, Monaco

    Toronto, Ontario – April 3, 2013 – Biologix Hair Inc. (OTCBB: BLGX; OTCQB: BLGX) announces that senior executives from the Company’s clinician licensing department will be exhibiting the Biologix Hair Therapy System™ to attendees at the Anti-Aging World Congress, Grimaldi Forum, being held in Monte Carlo, Monaco from April 4 – 6, 2013.

    Ron Holland, Biologix Hair Inc. CEO, commented, “The Anti-Aging Medicine World Congress is the world’s leading conference in the fields of aesthetic and anti-aging medicine. More than 8,000 professionals from over 95 countries will be in attendance discussing topical issues and medical advances. This is an excellent opportunity for Biologix to showcase its breakthrough hair loss solution to the leading edge of opinion makers within the international medical community.

    “We are determined to be in a ready position to capitalize on the high-margin sales potential of the Biologix Hair Therapy System™, if and when FDA and other major market approvals are forthcoming. Exhibiting at conferences such as the Annual Anti-Aging Medicine World Congress is expected to greatly assist Biologix in rapidly expanding its global distribution network of licensed clinicians and medical practitioners seeking to become Certified Biologix Hair Therapists™ and secure exclusive territorial purchasing and treatment rights for the Biologix Hair Therapy System™.”

    Biologix extends an open invitation to all attendees to visit the Biologix exhibit booth to learn more about the Biologix Hair Therapy System™ and how it can complement your current services and business revenues.

    For more information about the Annual Anti-Aging Medicine World Congress being held this week in Monaco, visit http://www.GrimaldiForum.com.

Viewing 1 replies (of 1 total)
  • Replies
Viewing 1 replies (of 1 total)
  • You must be logged in to reply to this topic.